Toxicity of inorganic arsenic salts.
D000208:Acute Disease; D001151:Arsenic / Q000009:adverse effects / Q000032:analysis / Q000266:history / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D020261:Arsenic Poisoning; D001152:Arsenicals; D001711:Biotransformation; D002273:Carcinogens; D002493:Central Nervous System Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury / Q000503:physiopathology; D002621:Chemistry; D002908:Chronic Disease; D004064:Digestive System / Q000187:drug effects; D006402:Hematologic Diseases / Q000139:chemically induced; D006439:Hemodynamics / Q000187:drug effects; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D049690:History, Ancient; D006801:Humans; D007408:Intestinal Absorption; D007674:Kidney Diseases / Q000139:chemically induced; D009153:Mutagens; D009422:Nervous System Diseases / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D013723:Teratogens; D014018:Tissue Distribution
D001152:Arsenicals; D002273:Carcinogens; D009153:Mutagens; D013723:Teratogens; D001151:Arsenic; C006633:arsine